About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
L
Single-Cell ERK Signalling Dynamics Drive Adaptive Drug Resistance of BRAF V600E Melanoma
By
Luca Gerosa
36 views
December 31, 2019
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
23:16
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update
2023 Updates on Dysplastic Nevi
Feat.
B. Kelley
20:10
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
Melanonychia Diagnosis, Evaluation, and Treatment
Feat.
F. Fish
13:47
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Tramet…
Feat.
V. Subbiah
23:09
Total Health
Key Updates in Skin Melanoma
Feat.
R. Seedor
29:26
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
Sun Exposure and Melanoma: Connecting the Dots
Feat.
D. Kent
06:39
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Final Analysis of Distant Metastasis-Free…
Feat.
J. Luke
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
17:39
Melanoma Bridge 2023
Major Emerging Paradigm Shifts That Will Change Melanoma Management …
Feat.
A. Eggermont
24:40
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
Pathology of Melanoma
Feat.
B. Kelley
23:57
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
Innovations in Diagnostic Techniques for Melanoma
Feat.
T. Blalock
05:20
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Impact of Immune Checkpoint Inhibition on…
Feat.
E. Buchbinder
08:38
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "A Phase 3 Trial Comparing Fianlimab + Cem…
Feat.
T. Panella
19:52
OncoAlert
Melanoma Updates: Adjuvant Therapy, Advanced Disease, Uveal Melanoma…
Feat.
A. Betof Warner
21:04
Penn Medicine Abramson Cancer Center
Pediatric Melanoma
Feat.
M. Jen
21:12
Robert Swerlick
Dealing With Melanoma Overdiagnosis: Can We Find an Off-Ramp?
05:37
Melanoma Bridge 2023
COLUMBUS 7-Year Update: Encorafenib + Binimetinib vs. Vemurafenib or…
Feat.
R. Dummer
08:46
Sapna Patel
Neoadjuvant Immunotherapy in the Treatment of Melanoma: What Do We K…
13:12
2023 Year in Review
Year in Review: Surgical Treatment of Acral Melanoma
Feat.
M. Leventer
14:00
Melanoma Bridge 2023
Is SLN Biopsy No Longer Necessary for Patients With High-Risk Primar…
Feat.
J. Luke
10:39
University of Colorado Department of Medicine
Cardio-Oncology: Definitions and Scope
Feat.
L. Kondapalli
